Cited by 346Pneumonia and Respiratory InfectionsT-cell and B-cell ImmunologyImmune responses and vaccinations

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

CD4 + T cells mediate antibody-independent acquired immunity to pneumococcal colonization

Open access

Malley, Richard, Trzcinski, Krzysztof, Srivastava, Amit, Thompson, Claudette M., Anderson, Porter W., Lipsitch, Marc·2005·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0501254102PMC PMC555733

Open this paper in CoChat — free account

Abstract

Acquired immunity to Streptococcus pneumoniae (pneumococcus) has long been assumed to depend on the presence of anticapsular antibodies. We found, however, that colonization with live pneumococci of serotypes 6B, 7F, or 14 protected mice against recolonization by any of the serotypes and that protection from acquisition of a heterologous or homologous strain did not depend on anticapsular antibody. Further, intranasal immunization by live pneumococcal colonization or by a killed, nonencapsulated whole-cell vaccine protected antibody-deficient mice against colonization, suggesting independence of antibodies to any pneumococcal antigens. Protection by intranasal immunization with whole-cell vaccine was completely abrogated in T cell-deficient mice, and in mice that were congenitally deficient in CD4 + T cells or depleted of these cells at the time of challenge. In contrast, mice congenitally deficient in, or depleted of, CD8 + T cells were fully protected. Protection in this model was observed beyond 2 months after immunization, arguing against innate or nonspecific immune mechanisms. Thus, we find that immunity to pneumococcal colonization can be induced in the absence of antibody, independent of the capsular type, and this protection requires the presence of CD4 + T cells at the time of challenge.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0501254102

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,371
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S. B., Shinefield, H. R., FIREMAN, B. H., Lewis, E. M., Ray, P., Hansen, J. R., Elvin, L., ENSOR, K. M., Hackell, J. G., Siber, G. R., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
Whitney, C. G., Farley, M. M., Hadler, J. L., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A. L., Cieslak, P. R., Pilishvili, T., Jackson, D. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,230
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
Kitamura, D., Roes, J., Kühn, R., & Rajewsky, K. (1991) · Nature · doi:10.1038/350423a0 · Cited by 1,783
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola, J., Kilpi, T. M., PALMU, A. A. I., Jokinen, J., Eerola, M., Haapakoski, J., Herva, E., Takala, A. K., Käyhty, H. M., Karma, P. H., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440602 · Cited by 1,454
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,009
Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient Patients
de Jong, R., Altare, F., Haagen, I.-A., Elferink, D. G., de Boer, T., Vriesman, P. J. C. V. B., Kabel, P. J., Draaisma, J. M. T., van Dissel, J. T., Kroon, F. P., et al. (1998) · Science · doi:10.1126/science.280.5368.1435 · Cited by 819
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor
Cundell, D. R., Gerard, N. P., Gerard, C. J., Idänpään‐Heikkilä, I., & TUOMANEN, E. I. (1995) · Nature · doi:10.1038/377435a0 · Cited by 741
Cutting Edge: Different Toll-Like Receptor Agonists Instruct Dendritic Cells to Induce Distinct Th Responses via Differential Modulation of Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase and c-Fos
Agrawal, S., Agrawal, A., Doughty, B. L., Gerwitz, A., Blenis, J., Dyke, T. E. V., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 740
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
Malley, R., Henneke, P., Morse, S. C., Cieslewicz, M. J., Lipsitch, M., Thompson, C. M., Kurt‐Jones, E. A., Paton, J. C., Wessels, M. R., & Golenbock, D. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435928100 · Cited by 704
Self-citation

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 2

World Health Organization (1998) Weekly Epidemiol. Records 73, 187-188.
Austrian, R. (1986) J. Antimicrob. Chemother. 18, Suppl. A, 35-45.

Sorted by citations

Items 101–200 of 346

The contrasting roles of Th17 immunity in human health and disease
Hoe, E., Anderson, J., Nathanielsz, J., Toh, Z. Q., Marimla, R. A., Balloch, A., & Licciardi, P. V. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12471 · Cited by 56
PspA Family Fusion Proteins Delivered by AttenuatedSalmonella entericaSerovar Typhimurium Extend and Enhance Protection againstStreptococcus pneumoniae
Xin, W., Li, Y., Mo, H., Roland, K. L., & Curtiss, R. (2009) · Infection and Immunity · doi:10.1128/iai.00486-09 · Cited by 51
Epidemiological Evidence for Serotype‐Independent Acquired Immunity to Pneumococcal Carriage
Granat, S., Ollgren, J. P., Herva, E., Mia, Z., Auranen, K. J., & Mäkelä, P. H. (2009) · The Journal of Infectious Diseases · doi:10.1086/599364 · Cited by 52
Distinct Effects on Diversifying Selection by Two Mechanisms of Immunity against Streptococcus pneumoniae
Li, Y., Gierahn, T. M., Thompson, C. M., Trzciński, K., Ford, C. B., Croucher, N. J., Gouveia, P., Flechtner, J. B., Malley, R., & Lipsitch, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002989 · Cited by 50
Self-citation
Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression
Joyce, E. A., Popper, S. J., & Falkow, S. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-404 · Cited by 51
Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
BLACK, S. B., Eskola, J., Whitney, C., & Shinefield, H. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50027-1 · Cited by 49
Human C-Reactive Protein Protects Mice from Streptococcus pneumoniae Infection without Binding to Pneumococcal C-Polysaccharide
Suresh, M. V., Singh, S. K., Ferguson, D. A., & Agrawal, A. C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1158 · Cited by 49
Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis
Foxwell, A. R., Cripps, A. W., & Dear, K. B. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001958.pub2 · Cited by 48
Retracted
Experimental human pneumococcal carriage models for vaccine research
Ferreira, D. M., Jambo, K., & Gordon, S. B. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.003 · Cited by 49
Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus
Martinez, P. J., Mathews, C. E., Actor, J. K., Hwang, S., Brown, E. L., Santiago, H. L. P. K.-D., Hoch, S. P. F., McCormick, J. B., & Mirza, S. (2013) · Translational research · doi:10.1016/j.trsl.2013.07.005 · Cited by 47
Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine
Moffitt, K. L., Yadav, P., Weinberger, D. M., Anderson, P. W., & Malley, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.034 · Cited by 47
Self-citation
C-Reactive Protein Enhances Immunity to Streptococcus pneumoniae by Targeting Uptake to FcγR on Dendritic Cells
Thomas-Rudolph, D., Clos, T. W. D., Snapper, C. M., & Mold, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7283 · Cited by 47
Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A)
Ferreira, D. M., Oliveira, M. L. S., Moreno, A. T., Ho, P. L., Briles, D. E., & Miyaji, E. N. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2010.02.009 · Cited by 46
Identification of Protective Pneumococcal TH17 Antigens from the Soluble Fraction of a Killed Whole Cell Vaccine
Moffitt, K. L., Malley, R., & Lu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043445 · Cited by 45
Self-citation
Defective Pneumococcal-Specific Th1 Responses in HIV-Infected Adults Precedes a Loss of Control of Pneumococcal Colonization
Glennie, S. J., Banda, D. H., Gould, K., Hinds, J., Kamng’ona, A. W., Everett, D., Williams, N., & Heyderman, R. S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis842 · Cited by 44
Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model
de Gouw, D., de Jonge, M. I., Hermans, P. W. M., Wessels, H. J. C. T., Zomer, A., Berends, A. J., Pratt, C. B., Berbers, G. A. M., Mooi, F. R., & Diavatopoulos, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105011 · Cited by 45
Intranasal Immunization with the Cholera Toxin B Subunit-Pneumococcal Surface Antigen A Fusion Protein Induces Protection against Colonization with Streptococcus pneumoniae and Has Negligible Impact on the Nasopharyngeal and Oral Microbiota of Mice
Pimenta, F. C., Miyaji, E. N., Arêas, A. P. M., Oliveira, M. L. S., de Andrade, A. L. S. S., Ho, P. L., Hollingshead, S. K., & Leite, L. C. C. (2006) · Infection and Immunity · doi:10.1128/iai.00134-06 · Cited by 44
Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses
Babb, R., Chen, A., Hirst, T. R., Kara, E. E., McColl, S. R., Ogunniyi, A. D., Paton, J. C., & Alsharifi, M. (2016) · Clinical Science · doi:10.1042/cs20150699 · Cited by 45
Prophylactic vaccine delivery systems against epidemic infectious diseases
Pan, C., Yue, H., Zhu, L., Ma, G., & Wang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113867 · Cited by 43
Effects of Developmental Activation of the AhR on CD4+ T-Cell Responses to Influenza Virus Infection in Adult Mice
Boulé, L. A., Winans, B., & Lawrence, B. P. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1408110 · Cited by 42
Role of Non-conventional T Lymphocytes in Respiratory Infections: The Case of the Pneumococcus
Ivanov, S., Paget, C., & Trottein, F. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004300 · Cited by 48
Potential role for mucosally active vaccines against pneumococcal pneumonia
Jambo, K., Sepako, E., Heyderman, R. S., & Gordon, S. B. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.12.001 · Cited by 41
Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection
Kock, C., Beineke, A., Seitz, M., Ganter, M., Waldmann, K.-H., Valentin‐Weigand, P., & Baums, C. G. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.05.009 · Cited by 41
Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage
Gray, C., Ahmed, M. S., Mubarak, A., Kasbekar, A. V., Derbyshire, S., McCormick, M. S., Mughal, M. K., McNamara, P. S., Mitchell, T. J., & Zhang, Q. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.89 · Cited by 41
Toll-Like Receptor 2-Dependent Protection against Pneumococcal Carriage by Immunization with Lipidated Pneumococcal Proteins
Moffitt, K. L., Škoberne, M., Howard, A. D., Gavrilescu, L. C., Gierahn, T. M., Munzer, J. S., Dixit, B. L., Giannasca, P. J., Flechtner, J. B., & Malley, R. (2014) · Infection and Immunity · doi:10.1128/iai.01632-13 · Cited by 41
Self-citation
Serine Protease PrtA from Streptococcus pneumoniae Plays a Role in the Killing of S. pneumoniae by Apolactoferrin
Mirza, S., Wilson, L. S., Benjamin, W. H., Novák, J., Barnes, S., Hollingshead, S. K., & Briles, D. E. (2011) · Infection and Immunity · doi:10.1128/iai.00489-10 · Cited by 41
Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation
Dagan, R. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1627207 · Cited by 41
Streptococcus pneumoniae
Janoff, E. N., & Musher, D. M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00201-0 · Cited by 42
Regulation of Production of Mucosal Antibody to Pneumococcal Protein Antigens by T-Cell-Derived Gamma Interferon and Interleukin-10 in Children
Zhang, Q., Bernatoniene, J., Bagrade, L., Paton, J. C., Mitchell, T. J., Hammerschmidt, S., Nunez, D. A., & Finn, A. H. R. (2006) · Infection and Immunity · doi:10.1128/iai.00165-06 · Cited by 41
Pneumococcal Vaccine and Patients with Pulmonary Diseases
Mirsaeidi, M. S., Ebrahimi, G., Allen, M. B., & Aliberti, S. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.010 · Cited by 40
A live‐attenuated pneumococcal vaccine elicits CD4+ T‐cell dependent class switching and provides serotype independent protection against acute otitis media
Rosch, J. W., Iverson, A., Humann, J., Mann, B., Gao, G., Vogel, P., Mina, M. J., Murrah, K. A., Perez, A. C., Swords, W. E., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202150 · Cited by 40
Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses
Davies, L. R. L., Cizmeci, D., Guo, W., Luedemann, C., Alexander-Parrish, R., Grant, L. R., Istúriz, R., Theilacker, C., Jódar, L., Gessner, B. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm4065 · Cited by 44
Pneumococcal Capsular Polysaccharide Immunity in the Elderly
Adler, H., Ferreira, D. M., Gordon, S. B., & Rylance, J. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00004-17 · Cited by 41
Development of pneumococcal vaccines over the last 10 years
Principi, N., & Esposito, S. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1384462 · Cited by 39
Generation of protective pneumococcal-specific nasal resident memory CD4+ T cells via parenteral immunization
O’Hara, J. M., Redhu, N. S., Cheung, E., Robertson, N. G., Patik, I., Sayed, S. E., Thompson, C. M., Herd, M., Lucas, K. B., Conaway, E. A., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0218-5 · Cited by 38
Self-citation
Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance
Balloch, A., Licciardi, P. V., Leach, A. J., Nurkka, A., & Tang, M. L. K. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.011 · Cited by 37
The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule
Ota, M. O. C., Akinsola, A., Townend, J., Antonio, M., Enwere, G., Nsekpong, D. E., Bojang, A., Saaka, M., Burton, R. L., Zaman, A., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.098 · Cited by 38
The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model
Bogaert, D., Thompson, C. M., Trzciński, K., Malley, R., & Lipsitch, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.085 · Cited by 38
Self-citation
Novel Protein-Based Pneumococcal Vaccines Administered with the Th1-Promoting Adjuvant IC31 Induce Protective Immunity against Pneumococcal Disease in Neonatal Mice
Olafsdottir, T. A., Lingnau, K., Nagy, E., & Jónsdóttir, I. (2011) · Infection and Immunity · doi:10.1128/iai.05801-11 · Cited by 35
The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development
Khan, M. N., & Pichichero, M. E. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.979631 · Cited by 38
Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age
Schmid, P., Selak, S., Keller, M., Luhan, B., Magyarics, Z., Seidel, S., Schlick, P., Reinisch, C., Lingnau, K., Nagy, E., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.081 · Cited by 36
Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae
Cui, Y., Zhang, X., Gong, Y., Niu, S., Yin, N., Yao, R., Xu, W., Li, D., Wang, H., He, Y., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.126 · Cited by 35
Mucosal Immunization with Polyamine Transport Protein D (PotD) Protects Mice Against Nasopharyngeal Colonization with Streptococcus pneumoniae
Shah, P., Briles, D. E., King, J. D., Hale, Y., & Swiatlo, E. (2009) · Experimental Biology and Medicine · doi:10.3181/0809-rm-269 · Cited by 35
Acquisition of Streptococcus pneumoniae in Pneumococcal Conjugate Vaccine-naïve South African Children and Their Mothers
Nunes, M. C., Shiri, T., van Niekerk, N., Cutland, C., Groome, M. J., Koen, A. L., von Gottberg, A., de Gouveia, L., Klugman, K. P., Adrian, P. V., et al. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31828683a3 · Cited by 35
Mucosal Immunity in Healthy Adults after Parenteral Vaccination with Outer‐Membrane Vesicles fromNeisseria meningitidisSerogroup B
Davenport, V., Groves, E., Horton, R. E., Hobbs, C., Guthrie, T., Findlow, J., Borrow, R., Næss, L. M., Oster, P., Heyderman, R. S., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590669 · Cited by 35
New insights into pneumococcal disease
Feldman, C. H., & Anderson, R. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01422.x · Cited by 34
Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen
Kuipers, K., Jong, W. S. P., Jongh, C. E. V. D. G., Houben, D., van Opzeeland, F. J., Simonetti, E. R., van Selm, S., de Groot, R., Koenders, M. I., Azarian, T., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00281-17 · Cited by 34
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
Voß, F., Kohler, T. P., Meyer, T. C., Abdullah, M. R., van Opzeeland, F. J., Saleh, M., Michalik, S., van Selm, S., Schmidt, F., de Jonge, M. I., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02405 · Cited by 34
Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection
Chattopadhyay, A., Park, S., Delmas, G., Suresh, R., Senina, S., Perlin, D. S., & Rose, J. K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.031 · Cited by 32
CD4 T Cell Memory and Antibody Responses Directed against the Pneumococcal Histidine Triad Proteins PhtD and PhtE following Nasopharyngeal Colonization and Immunization and Their Role in Protection against Pneumococcal Colonization in Mice
Khan, M. N., & Pichichero, M. E. (2013) · Infection and Immunity · doi:10.1128/iai.00313-13 · Cited by 32
Lactobacillus rhamnosus CRL1505 nasal administration improves recovery of T-cell mediated immunity against pneumococcal infection in malnourished mice
Barbieri, N., Herrera, M., Salva, S., Villena, J., & Alvarez, S. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0152 · Cited by 34
A Human Monoclonal Immunoglobulin M Reduces Bacteremia and Inflammation in a Mouse Model of Systemic Pneumococcal Infection
Fabrizio, K., Groner, A., Boes, M. L., & Pirofski, L. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00374-06 · Cited by 31
Streptococcus pneumoniae virulence factors and their clinical impact: an update
Garcı́a-Suárez, M. D. M., Vázquez, F., & Méndez, F. J. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13092469 · Cited by 32
Monocytes Regulate the Mechanism of T-cell Death by Inducing Fas-Mediated Apoptosis during Bacterial Infection
Daigneault, M., de Silva, T. I., Bewley, M. A., Preston, J. A., Marriott, H. M., Mitchell, A. M., Mitchell, T. J., Read, R. C., Whyte, M. K. B., & Dockrell, D. H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002814 · Cited by 33
Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection
Wright, A. K. A., Briles, D. E., Metzger, D. W., & Gordon, S. B. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.058 · Cited by 30
Differential Requirements for Protection against Mucosal Challenge with Francisella tularensis in the Presence versus Absence of Cholera Toxin B and Inactivated F. tularensis
Bitsaktsis, C., Rawool, D. B., Li, Y., Kurkure, N. V., Iglesias, B. V., & Gosselin, E. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803242 · Cited by 31
Lung Fluid Immunoglobulin from HIV-Infected Subjects Has Impaired Opsonic Function against Pneumococci
Eagan, R. E., Twigg, H. L., French, N., Musaya, J., Day, R. B., Zijlstra, E. E., Tolmie, H., Wyler, D. K., Molyneux, M. E., & Gordon, S. B. (2007) · Clinical Infectious Diseases · doi:10.1086/518133 · Cited by 31
Density, Serotype Diversity, and Fitness ofStreptococcus pneumoniaein Upper Respiratory Tract Cocolonization With NontypeableHaemophilus influenzae
Lewnard, J. A., Huppert, A., Givon‐Lavi, N., Pettigrew, M. M., Regev‐Yochay, G., Dagan, R., & Weinberger, D. M. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw381 · Cited by 34
Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children
Simell, B., Ahokas, P., Lahdenkari, M., POOLMAN, J. T., Henckaerts, I., Kilpi, T. M., & Käyhty, H. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.071 · Cited by 30
Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection
Khan, M. N., Xu, Q., & Pichichero, M. E. (2016) · Infection and Immunity · doi:10.1128/iai.00530-16 · Cited by 32
Reduced T-Helper 17 Responses to Streptococcus pneumoniae in Infection-Prone Children Can Be Rescued by Addition of Innate Cytokines
Basha, S., Kaur, R., Mosmann, T. R., & Pichichero, M. E. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix090 · Cited by 29
Mouse models for the study of mucosal vaccination against otitis media
Sabirov, A., & Metzger, D. W. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.029 · Cited by 30
Characterization of the Inflammatory Infiltrate in Streptococcus pneumoniae Pneumonia in Young and Elderly Patients
Menter, T., Giefing-Kroell, C., Grubeck‐Loebenstein, B., & Tzankov, A. (2014) · Pathobiology · doi:10.1159/000360165 · Cited by 29
Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults
Baril, L., Dietemann, J., Essevaz-Roulet, M., Béniguel, L., Coan, P., Briles, D. E., Guy, B., & Cozon, G. J. N. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03148.x · Cited by 31
Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections
Broecker, F., Wegner, E., Seco, B. M. S., Kapłonek, P., Bräutigam, M., Ensser, A., Pfister, F., Daniel, C., Martin, C. E., Mattner, J., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00642 · Cited by 29
Anatomical site-specific contributions of pneumococcal virulence determinants
Shenoy, A. T., & Orihuela, C. J. (2016) · Pneumonia · doi:10.1186/s41479-016-0007-9 · Cited by 28
Models of immune selection for multi-locus antigenic diversity of pathogens
Georgieva, M., Buckee, C. O., & Lipsitch, M. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0092-5 · Cited by 28
Self-citation
NADH Oxidase Functions as an Adhesin in Streptococcus pneumoniae and Elicits a Protective Immune Response in Mice
Muchnik, L., Adawi, A., Ohayon, A., Dotan, S., Malka, I., Azriel, S., Shagan, M., Portnoi, M., Kafka, D., Nahmani, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061128 · Cited by 28
Serum Antipneumococcal Antibodies and Pneumococcal Colonization in Adults with Chronic Obstructive Pulmonary Disease
Malley, R., Lipsitch, M., Bogaert, D., Thompson, C. M., Hermans, P. W. M., Watkins, A. C., Sethi, S., & Murphy, T. F. (2007) · The Journal of Infectious Diseases · doi:10.1086/520937 · Cited by 29
Self-citation
Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection
Kye, Y.-C., Park, S., Shim, B.-S., Firdous, J., Kim, G., Kim, H. W., Ju, Y.-J., Kim, C. G., Cho, C., Kim, D. W., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.03.049 · Cited by 29
Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults
Chen, M., Ssali, F. N., Mulungi, M., Awio, P., Yoshimine, H., Kuroki, R., Furumoto, A., Tanimura, S., Kityo, C. M., Nagatake, T., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.093 · Cited by 27
Impaired Function of Antibodies to Pneumococcal Surface Protein A but Not to Capsular Polysaccharide in Mexican American Adults with Type 2 Diabetes Mellitus
Mathews, C. E., Brown, E. L., Martinez, P. J., Bagaria, U., Nahm, M. H., Burton, R. L., Fisher‐Hoch, S. P., McCormick, J. B., & Mirza, S. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00268-12 · Cited by 27
Antibodies to Pneumococcal Surface Protein A Families 1 and 2 in Serum and Saliva of Children and the Risk of Pneumococcal Acute Otitis Media
Simell, B., Melin, M. M., Lahdenkari, M., Briles, D. E., Hollingshead, S. K., Kilpi, T. M., & Käyhty, H. M. (2007) · The Journal of Infectious Diseases · doi:10.1086/522607 · Cited by 26
Controlled Inflammatory Responses in the Lungs Are Associated with Protection Elicited by a Pneumococcal Surface Protein A-Based Vaccine against a Lethal Respiratory Challenge with Streptococcus pneumoniae in Mice
Lima, F. A., Ferreira, D. M., Moreno, A. T., Ferreira, P. C. D., Palma, G. M. P., Ferreira, J. M. C., Raw, I., Miyaji, E. N., Ho, P. L., & Oliveira, M. L. S. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00171-12 · Cited by 26
Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
Klugman, K. P., BLACK, S. B., Dagan, R., Malley, R., & Whitney, C. G. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00032-x · Cited by 27
Self-citation
Tissue-Expressed B7x Affects the Immune Response to and Outcome of Lethal Pulmonary Infection
Hofmeyer, K. A., Scandiuzzi, L., Ghosh, K., Pirofski, L., & Zang, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200701 · Cited by 24
Future Perspective on Host–Pathogen Interactions During Bacterial Biofilm Formation within the Nasopharynx
Blanchette, K. A., & Orihuela, C. J. (2012) · Future Microbiology · doi:10.2217/fmb.11.160 · Cited by 24
IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine
de Campos, I. B., Herd, M., Moffitt, K. L., Lu, Y., Darrieux, M., Malley, R., Leite, L. C. C., & Gonçalves, V. M. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.030 · Cited by 25
Self-citation
Maturation of Mucosal Immune Responses and Influence of Maternal Antibodies
Jónsdóttir, I. (2007) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2007.04.007 · Cited by 24
Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model
Whaley, M. J., Sampson, J. S., Johnson, S. E., Rajam, G., Stinson-Parks, A., Holder, P. F., Mauro, E., Romero‐Steiner, S., Carlone, G. M., & Ades, E. W. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.086 · Cited by 24
CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens
Sharma, S., Roumanes, D., Almudevar, A., Mosmann, T. R., & Pichichero, M. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.060 · Cited by 24
Identification of the Targets of Cross-Reactive Antibodies Induced byStreptococcus pneumoniaeColonization
Roche, A. M., & Weiser, J. N. (2010) · Infection and Immunity · doi:10.1128/iai.01058-09 · Cited by 24
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
Morais, V., & Suárez, N. (2022) · Bioengineering · doi:10.3390/bioengineering9120774 · Cited by 23
The Impact of the Heptavalent Pneumococcal Conjugate Vaccine on Risk Factors for Streptococcus pneumoniae Carriage in Children
Hsieh, Y., Chiu, C., Chang, K.-Y., Huang, Y., Chen, C., Kuo, C.-Y., Chen, P.-Y., Hwang, K., & Lin, T. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31825cb9f9 · Cited by 23
Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
Gordon, S. B., Malamba, R., Mthunthama, N., Jarman, E. R., Jambo, K., Jere, K. C., Zijlstra, E. E., Molyneux, M. E., Dennis, J., & French, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.082 · Cited by 23
Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination
Masala, G. L., Lipsitch, M., Bottomley, C., & Flasche, S. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0620 · Cited by 22
Self-citation
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy
Grant, L. R., Slack, M., Yan, Q., Trzciński, K., Barratt, J., Sobczyk, E. A., Appleby, J. C., Cane, A. D., Jódar, L., Istúriz, R., et al. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1921579 · Cited by 22
Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium
Liberman, C., Takagi, M., Cabrera-Crespo, J., Sbrogio-Almeida, M. E., Dias, W. O., Leite, L. C. C., & Gonçalves, V. M. (2008) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-008-0445-3 · Cited by 22
Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response
HogenEsch, H., Dunham, A. D., Hansen, B., Anderson, K., Maisonneuve, J.-F., & Hem, S. L. (2011) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-9-5 · Cited by 22
NonencapsulatedStreptococcus pneumoniaeresists extracellular human neutrophil elastase- and cathepsin G-mediated killing
van der Windt, D., Bootsma, H. J., Burghout, P., Jongh, C. E. V. D. G., Hermans, P. W. M., & van der Flier, M. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.01028.x · Cited by 21
Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization
Keller, L. E., Luo, X., Thornton, J. A., Seo, K. S., Moon, B. Y., Robinson, D. A., & McDaniel, L. S. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00456-15 · Cited by 21
Serum Antibodies to Pneumococcal Neuraminidase NanA in Relation to Pneumococcal Carriage and Acute Otitis Media
Simell, B., Jaakkola, T., Lahdenkari, M., Briles, D. E., Hollingshead, S. K., Kilpi, T. M., & Käyhty, H. M. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00257-06 · Cited by 21
Epidemiologic and Microbiologic Characteristics of Recurrent Bacterial and Fungal Meningitis in The Netherlands, 1988–2005
van Driel, J. J., Bekker, V., Spanjaard, L., ENDE, A. V. D., & Kuijpers, T. W. (2008) · Clinical Infectious Diseases · doi:10.1086/590251 · Cited by 19
Mucosal Immunization with the Live Attenuated Vaccine SPY1 Induces Humoral and Th2-Th17-Regulatory T Cell Cellular Immunity and Protects against Pneumococcal Infection
Xu, X., Wang, H., Liu, Y., Wang, Y., Zeng, L., Wu, K., Wang, J., Ma, F., Xu, W., Yin, Y., et al. (2014) · Infection and Immunity · doi:10.1128/iai.02334-14 · Cited by 20
A novel flow cytometry-based assay for the quantification of antibody-dependent pneumococcal agglutination
Habets, M. N., van Selm, S., Jongh, C. E. V. D. G., Diavatopoulos, D. A., & de Jonge, M. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170884 · Cited by 20
Bacterial Lipoproteins Differentially Regulate Human Primary and Memory CD4+ T and B Cell Responses to Pneumococcal Protein Antigens through Toll‐Like Receptor 2
Zhang, Q., Bagrade, L., Clarke, E., Paton, J. C., Nunez, D. A., & Finn, A. H. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/652495 · Cited by 20
A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi
Lu, Y., Zhang, F., Sayeed, S., Thompson, C. M., Szu, S. C., Anderson, P. W., & Malley, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.03.039 · Cited by 19
Self-citation
Nongenetically modified Lactococcus lactis‐adjuvanted vaccination enhanced innate immunity against Helicobacter pylori
Liu, W., Tan, Z., Liu, H., Zeng, Z., Luo, S., Yang, H., Zheng, L., Xi, T., & Xing, Y. (2017) · Helicobacter · doi:10.1111/hel.12426 · Cited by 19
Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection
Cao, J., Li, D., Gong, Y., Yin, N., Chen, T., Wong, C. K., Xu, W., Luo, J., Zhang, X., Lam, C. W. K., et al. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03866.x · Cited by 19
SERUM ANTIBODIES TO THE PNEUMOCOCCAL SURFACE PROTEINS PhtB AND PhtE IN FINNISH INFANTS AND ADULTS
Holmlund, E., Simell, B., Jaakkola, T., Lahdenkari, M., Hamel, J., Brodeur, B. R., Kilpi, T. M., & Käyhty, H. M. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000261198.90649.04 · Cited by 19

Authors: Malley, R., Trzcinski, K., Srivastava, A., Thompson, C. M., Anderson, P. W., & Lipsitch, M.
Affiliations: Boston Children's Hospital (US)
Division of Infectious Diseases, Department of Medicine, Children's Hospital and Harvard Medical School, Boston, MA 02115; Departments of Epidemiology and Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02215; and Department of Pediatrics, University of Rochester, Rochester, NY 14627
ORCID: Malley, Richard
Srivastava, Amit
Lipsitch, Marc
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2005-03-21
Volume: 102
Issue: 13
Pages: 4848-4853
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0501254102
PMC: PMC555733
OpenAlex: W2138424202
Cited by: 346
References: 35
Citations by year: 2026: 12 · 2025: 9 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 11 · 2018: 15 · 2017: 27 · 2016: 14 · 2015: 18 · 2014: 23 · 2013: 22 · 2012: 29
FWCI: 14.57
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders: National Institute of Allergy and Infectious Diseases (K08 AI51526-01, K08AI051526, AI07061-26, R01AI048935, T32AI007061)
Topics: Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: Streptococcus pneumoniae, pneumococcal carriage, CD4+ T cells, antibody-independent immunity, adaptive immunity, CD8+ T cells, whole-cell vaccine, intranasal immunization, antibody deficiency, T cell-deficient mice, serotype 6B, serotype 7F, serotype 14, mucosal immunity
MeSH terms: Administration, Intranasal, Animals, Enzyme-Linked Immunosorbent Assay, Female, Immunity, Cellular, Mice, Inbred C57BL, Pneumococcal Infections, Species Specificity, Streptococcus pneumoniae, Time Factors, CD4-Positive T-Lymphocytes, Streptococcal Vaccines, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CD4 + T cells mediate antibody-independent acquired immunity to pneumococcal colonization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks